Alimuddin I. Zumla
Alimuddin I. Zumla publishes mostly in Infectious Diseases, Epidemiology and Surgery, on topics such as Tuberculosis Research and Epidemiology, Diagnosis and treatment of tuberculosis and Mycobacterium research and diagnosis.
- World rank
- #23,063 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #1,671 of 367,258
- Works
- 1,152
- Citations
- 100k
- Citations per work
- 87.1
What does Alimuddin I. Zumla research?
Alimuddin I. Zumla's work is mostly in Medicine (57%), Immunology and Microbiology (4%), Health Professions (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences70260.9%
- Medicine65957.2%
- Health Professions433.7%
- Everything else40635.2%
- Life Sciences453.9%
- 1Infectious Diseases26% of their works
- 2Epidemiology14% of their works
- 3Surgery9% of their works
- 4Public Health, Environmental and Occupational Health8% of their works
- 5Immunology4% of their works
- 6General Health Professions4% of their works
Research topics
- Tuberculosis Research and Epidemiology
- Diagnosis and treatment of tuberculosis
- Mycobacterium research and diagnosis
- Pneumocystis jirovecii pneumonia detection and treatment
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Pneumonia and Respiratory Infections
- Infectious Diseases and Tuberculosis
Which keywords describe Alimuddin I. Zumla's research?
The keywords of their largest research topics: Epidemiology, Diagnosis, Treatment, Vaccine, Immune Response, Mycobacterium tuberculosis, Tuberculosis and ACE2 Receptor.
- Spinal Epidural Abscess
- Community-Acquired Pneumonia
- Clinical Characteristics
- Coronavirus
- Pneumocystis
- Mycobacterium avium
- Abdominal Tuberculosis
- Antiretroviral Therapy
- ACE2 Receptor
- Mycobacterium tuberculosis
- Vaccine
- Diagnosis
- Epidemiology
- Treatment
- Immune Response
- Tuberculosis
- SARS-CoV-2
- Clinical Practice Guidelines
- Diagnostic Challenges
- Nontuberculous Mycobacteria
- Pneumonia
- spike protein
- Thrombosis
- Pneumococcal Conjugate Vaccine
- Tuberculous Meningitis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 25 words, with their numbers
- Epidemiology8115 topics
- Diagnosis6233 topics
- Treatment6233 topics
- Vaccine5062 topics
- Immune Response4952 topics
- Mycobacterium tuberculosis4001 topic
- Tuberculosis4001 topic
- ACE2 Receptor2012 topics
- SARS-CoV-22012 topics
- Antiretroviral Therapy1972 topics
- Clinical Practice Guidelines1822 topics
- Abdominal Tuberculosis1341 topic
- Diagnostic Challenges1341 topic
- Mycobacterium avium1151 topic
- Nontuberculous Mycobacteria1151 topic
- Pneumocystis1081 topic
- Pneumonia1081 topic
- Coronavirus1061 topic
- spike protein1061 topic
- Clinical Characteristics951 topic
- Thrombosis951 topic
- Community-Acquired Pneumonia931 topic
- Pneumococcal Conjugate Vaccine931 topic
- Spinal Epidural Abscess891 topic
- Tuberculous Meningitis891 topic
Where does Alimuddin I. Zumla work?
Alimuddin I. Zumla's main affiliation in the publication record is University College London, United Kingdom.
How many publications and citations does Alimuddin I. Zumla have?
OpenAlex counts 1,152 works and 100,307 citations for Alimuddin I. Zumla, an h-index of 141, ranking #23,063 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Alimuddin I. Zumla. Posts are plain text and can be reported.